Assays for identifying receptors having alterations in signaling

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20020127539A1
SERIAL NO

09966871

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides methods of identifying receptors having altered signaling. In particular, the present invention provides an assay for the identification of receptors having alterations in ligand dependent or ligand independent signaling. Receptors having alterations in ligand dependent signaling that can be identified by the inventive method include hypersensitive hyposensitive receptors and receptors having increased or decreased potency. The inventive method is also applicable to the identification of receptors having alterations in basal activity, for example, constitutively active receptors or receptors having silencing mutations. Further applications include the identification of polymorphic or mutant receptors having alterations in signaling and receptors having an altered drug response. Finally, the receptors identified are useful as tools for drug discovery.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
NEW ENGLAND MEDICAL CENTER HOSPITALS INC750 WASHINGTON STREET BOX 817 BOSTON MASSACHUSETTS 02111

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Beinborn, Martin Boston, MA 15 105
Kopin, Alan S Wellesley, MA 24 80

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation